MENU
CGEN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Compugen (CGEN) Earnings Date & Reports

Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

CGEN is expected to report earnings to rise 23.86% to -8 cents per share on February 19

Compugen CGEN Stock Earnings Reports
Q4'25
Est.
$-0.09
Q3'25
Est.
$-0.07
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.01
Q4'24
Missed
by $0.09
The last earnings report on November 10 showed earnings per share of -7 cents, meeting the estimate of -7 cents. With 120.32K shares outstanding, the current market capitalization sits at 159.44M.
View a ticker or compare two or three
CGEN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CGEN showed earnings on November 10, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information

General Information

a maker of drug and diagnostics

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
26 Harokmim Street
Phone
+972 37658585
Employees
68
Web
https://www.cgen.com